22-30580108-G-A
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 2P and 6B. PM2BP4_StrongBP6_Moderate
The ENST00000354694.12(PES1):c.1114C>T(p.Arg372Cys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000341 in 1,613,992 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Consequence
ENST00000354694.12 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -4 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PES1 | NM_014303.4 | c.1114C>T | p.Arg372Cys | missense_variant | 11/15 | ENST00000354694.12 | NP_055118.1 | |
PES1 | NM_001243225.2 | c.1099C>T | p.Arg367Cys | missense_variant | 11/15 | NP_001230154.1 | ||
PES1 | NM_001282327.1 | c.697C>T | p.Arg233Cys | missense_variant | 13/17 | NP_001269256.1 | ||
PES1 | NM_001282328.1 | c.697C>T | p.Arg233Cys | missense_variant | 13/17 | NP_001269257.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PES1 | ENST00000354694.12 | c.1114C>T | p.Arg372Cys | missense_variant | 11/15 | 1 | NM_014303.4 | ENSP00000346725 | P3 |
Frequencies
GnomAD3 genomes AF: 0.0000131 AC: 2AN: 152168Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000756 AC: 19AN: 251334Hom.: 0 AF XY: 0.000103 AC XY: 14AN XY: 135822
GnomAD4 exome AF: 0.0000363 AC: 53AN: 1461824Hom.: 1 Cov.: 33 AF XY: 0.0000440 AC XY: 32AN XY: 727214
GnomAD4 genome AF: 0.0000131 AC: 2AN: 152168Hom.: 0 Cov.: 33 AF XY: 0.0000134 AC XY: 1AN XY: 74350
ClinVar
Submissions by phenotype
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 03, 2024 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at